Volume 9, Issue 3 (Vol.9 No.3 Oct 2020)                   rbmb.net 2020, 9(3): 366-372 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khanam J, Hossain D, Hosen B, Uddin M, Kabir A, Bari M A. Association of Glutathione S-Transferase theta 1 and mu 1 Genes Polymorphisms with the Susceptibility of Myocardial Infarction in Bangladesh. rbmb.net. 2020; 9 (3) :366-372
URL: http://rbmb.net/article-1-463-en.html
Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh & National Forensic DNA Profiling Laboratory, Dhaka Medical College, Dhaka, Bangladesh.
Abstract:   (235 Views)
Background: Myocardial infarction is one of the leading causes of morbidity and mortality worldwide. Oxidative stress plays a vital role in the pathogenesis of atherosclerosis leading to myocardial infarction and Glutathione S-transferases (GSTs) act as detoxifying enzymes to reduce oxidative stress. The aim of the present study was to investigate the associations of the GST (T1 & M1) gene polymorphism with the susceptibility of myocardial infarction in the Bangladeshi population.

Methods: A case-control study on 100 cardiac patients with MI and 150 control subjects was conducted. The genotyping of GST (T1 & M1) gene was done using conventional Polymerase Chain Reaction.

Results: The percentage of GSTM1 genotypes was significantly (p< 0.01) lower in patients compared to control subjects while the GSTT1 genotypes were not significantly different between the study subjects. The individual with GSTM1 null allele was at 2.5-fold increased risk {odds ratio (OR)= 2.5; 95 % confidence interval (95 % CI)= 1.4 to 4.3; p< 0.01} of experiencing MI while individual with either GSTM1 or GSTT1 genotypes was at lower risk. In the case of GST M1 and GST T1 combined genotype, patients having both null genotypes for GST M1 and GST T1 gene showed significantly (p< 0.01) higher risk of experiencing MI when compared to control subjects (OR= 3.5; 95% CI= 1.7–7.2; p< 0.001).

Conclusions: Thus our recent study suggested that GSTM1 alone and GSTM1 and T1 in combination augments the risk of MI in Bangladeshi population.
Full-Text [PDF 183 kb]   (60 Downloads)    
Type of Article: Original Article | Subject: Molecular Biology
Received: 2020/02/10 | Accepted: 2020/03/1 | Published: 2020/12/1

References
1. Gouvinhas C, Severo M, Azevedo A, Lunet N. Worldwide patterns of ischemic heart disease mortality from 1980 to 2010. International Journal of Cardiology. 2014;170(3):309-314. [DOI:10.1016/j.ijcard.2013.11.004] [PMID]
2. World Health Organization (WHO). http://www.who.int/cardiovascular_diseases. [Accessed on July 21, 2019].
3. Smith F, Lee A, Fowkes F, Price J, Rumley A, Lowe GD. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. 1997;17(11):3321-3325. [DOI:10.1161/01.ATV.17.11.3321] [PMID]
4. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91(3A):7A-11A. [DOI:10.1016/S0002-9149(02)03144-2]
5. De flora S, Izzotti A, Walsh D, Degan P, Petrilli GL, Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J. 1997;11(12):1021-31. [DOI:10.1096/fasebj.11.12.9337155] [PMID]
6. Penn A, Snyder C. Arteriosclerotic plaque development is promoted by polynuclear aromatic hydrocarbons. Carcinogenesis. 1998;9(12):2185-2189. [DOI:10.1093/carcin/9.12.2185] [PMID]
7. Van Schooten FJ, Hirvonen A, Maas LM, De Mol BA, Kleinjans JC, Bell DA, et al. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking and aromatic DNA adducts levels in human right atrial tissue. FASEB J. 1998;12(13):1409-17 [DOI:10.1096/fasebj.12.13.1409] [PMID]
8. Prins BP, Lagou V, Asselbergs FW, Snieder H, Fu J. Genetics of coronary artery disease: genome-wide association studies and beyond. Atherosclerosis. 2012;225(1):1-10. [DOI:10.1016/j.atherosclerosis.2012.05.015] [PMID]
9. Ryberg D, Skaug V, Hewer A, Philips DH, Harries LW, Wolf CR. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 1997;18(7):1285-9. [DOI:10.1093/carcin/18.7.1285] [PMID]
10. Yalin S, Hatungil R, Tamer L, Ates NA, Dogruer N, Yildirim H, et al. Glutathione S-transferase gene polymorphisms in Turkish patients with diabetes mellitus. Cell Biochem Funct. 2007;25(5):509-13. [DOI:10.1002/cbf.1339] [PMID]
11. Azarpira N, Nikeghbalian S, Geramizadeh B, Darai M. Influence of glutathione S-transferase M1 and T1 polymorphisms with acute rejection in Iranian liver transplant recipients. Mol Bio Rep. 2010;37(1):21-25. [DOI:10.1007/s11033-009-9487-5] [PMID]
12. Rafiee L, Saadat I, Saadat M. Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep. 2010;37(1):155-8. [DOI:10.1007/s11033-009-9565-8] [PMID]
13. Saadat I, Saadat M. Influence of genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) on hematological parameters. Mol Biol Rep. 2010;37(1):249-53. [DOI:10.1007/s11033-009-9662-8] [PMID]
14. Katoh T, Yamano Y, Tsuji M, Watanabe M. Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer. Pharmacogenomics. 2008;9(1):93-104. [DOI:10.2217/14622416.9.1.93] [PMID]
15. Miller EA, Pankow JS, Millikan RC, Bray MS, Ballantyne CM, Bell DA, et al. Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis. 2003;171(2):265-272. [DOI:10.1016/j.atherosclerosis.2003.07.007] [PMID]
16. Khan MA, Baseer A. Increased malondialdehyde levels in coronary heart disease. J Pak Med Assoc. 2000;50(8):261-64.
17. Wilson M, Grant P, Hardie L, Wild CP. Glutathione-Stransferase M1-null genotype is associated with a decreased risk of myocardial infarction. FASEB J. 2000;14(5):791-6. [DOI:10.1096/fasebj.14.5.791] [PMID]
18. Masetti S, Botto N, Manfredi S, Colombo MG, Rizza A, Vassalle C, et al. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med (Berl). 2003;81(8):488-94. [DOI:10.1007/s00109-003-0448-5] [PMID]
19. Tamer L, Ercan B, Camsari A, Yildirim H, Ciçek D, Sucu N, et al. Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Res Cardiol. 2004;99(3):223-9. [DOI:10.1007/s00395-004-0465-8] [PMID]
20. Kim SJ, Kim MG, Kim KS, Song JS, Yim SV, Chung JH. Impact of glutathione S-transferase M1 and T1 gene polymorphisms on the smoking-related coronary artery disease. J Korean Med Sci. 2008;23(3):365-372. https://doi.org/10.3346/jkms.2008.23.3.365 [DOI:10.3346/jkms.2003.18.3.365] [PMID] [PMCID]
21. Singh N, Sinha N, Kumar S, Pandey CM, Agrawal S. Glutathione S-transferase gene polymorphism as a susceptibility factor for acute myocardial infarction and smoking in the North Indian population. Cardiology. 2011;118(1):16-21. [DOI:10.1159/000324066] [PMID]
22. Yeh HL, Kuo LT, Sung FC, Chiang CW, Yeh CC. GSTM1, GSTT1, GSTP1 and GSTA1 genetic variants are not associated with coronary artery disease in Taiwan. Gene. 2013;523(1): 64-9. [DOI:10.1016/j.gene.2013.02.052] [PMID]
23. Bhat MA, Gandhi G. Association of GSTT1 and GSTM1 gene polymorphisms with coronary artery disease in North Indian Punjabi population: a case-control study. Postgrad Med J. 2016;92(1094):701-706. [DOI:10.1136/postgradmedj-2015-133836] [PMID]
24. Wang LS, Tang JJ, Tang NP, Wang MW, Yan JJ, Wang QM, et al. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking. Clin Chem Lab Med. 2008;46(12):1720-5. [DOI:10.1515/CCLM.2008.353] [PMID]
25. Nomani H, Mozafari H, Ghobadloo SM, Rahimi Z, Raygani AV, Rahimi MA, et al. The association between GSTT1, M1 and P1 polymorphisms with coronary artery disease in Western Iran. Mol Cell Biochem. 2011;354(1-2):181-7. [DOI:10.1007/s11010-011-0817-2] [PMID]
26. World Medical Association. World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. [DOI:10.1001/jama.2013.281053] [PMID]
27. Akther L, Rahman MM, Bhuiyan MES, Hosen MB, Nesa A, Kabir Y. Association of Glutathione S-transferase theta 1 (GSTT1) and Glutathione S-transferase mu 1 (GSTM1) gene polymorphism with the risk of preeclampsia during pregnancy in Bangladesh. J Obstet Gynaecol Res. 2019;45(1):113-118. [DOI:10.1111/jog.13791] [PMID]
28. Hosen MB, Salam MA, Islam MF, Howlader MZH, Hossain A, Kabir Y. Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population. Tumour Biol. 2015;36(8):6369-74. [DOI:10.1007/s13277-015-3324-3] [PMID]
29. Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Cabrini G, et al. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. J Am Coll Cardiol. 2001;37(7):1808-12. [DOI:10.1016/S0735-1097(01)01237-2]
30. Cine N, Hatemi AC, Erginel‐Unaltuna N. Association of a polymorphism of the ecNOS gene with myocardial infarction in a subgroup of Turkish MI patients. Clin genet. 2002;61(1):66-70. [DOI:10.1034/j.1399-0004.2002.610113.x] [PMID]
31. Oniki K, Hori M, Takata K, Yokoyama T, Mihara S, Marubayashi T, et al. Association between glutathione Stransferase A1, M1 and T1 polymorphisms and hypertension. Pharmacogenet Genomic. 2008;18(3):275-7. [DOI:10.1097/FPC.0b013e3282f56176] [PMID]
32. Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N. T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Med Genet. 2006;7:38. [DOI:10.1186/1471-2350-7-38] [PMID] [PMCID]
33. Girisha KM, Gilmour A, Mastana S, Singh VP, Sinha N, Tewari S, et al. T1 and M1 polymorphism in glutathione S-transferase gene and coronary artery disease in North Indian population. Indian J Med Sci. 2004;58:520-6.
34. Syed R, Deeba F, Jamil K. Role of GSTM1 gene polymorphism and its association with coronary artery disease. Journal of Clinical Medicine Research. 2010;2:22-25.
35. Manfredi S, Federici C, Picano E, Botto N, Rizza A, Andreassi MG. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Mut Res. 2007;621(1-2):106-12. [DOI:10.1016/j.mrfmmm.2007.02.014] [PMID]
36. Cora T, Tokae M, Acar H, Soylu A, Inan Z. Glutathione S-transferase M1 and T1 genotypes and myocardial infarction. Mol Biol Rep. 2013;40(4):3263-7. [DOI:10.1007/s11033-012-2401-6] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2015 All Rights Reserved | Reports of Biochemistry and Molecular Biology

Designed & Developed by : Yektaweb